Correlation Between Surrozen and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Surrozen and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Surrozen and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and Day One.

Diversification Opportunities for Surrozen and Day One

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Surrozen and Day is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Surrozen i.e., Surrozen and Day One go up and down completely randomly.

Pair Corralation between Surrozen and Day One

Given the investment horizon of 90 days Surrozen is expected to under-perform the Day One. In addition to that, Surrozen is 2.7 times more volatile than Day One Biopharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about 0.04 per unit of volatility. If you would invest  1,267  in Day One Biopharmaceuticals on November 1, 2024 and sell it today you would earn a total of  19.00  from holding Day One Biopharmaceuticals or generate 1.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Surrozen  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Surrozen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Surrozen may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Surrozen and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Surrozen and Day One

The main advantage of trading using opposite Surrozen and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Surrozen and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance